secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2024-10-21T23:59:59+00:00
Accession:  0001193125-24-240034
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Finch Therapeutics initiates Nasdaq delisting; plans SEC deregistration by Nov 11
--------------------------------------------------------------------------------

- Board determined to delist common stock from Nasdaq; Form 25 to be filed on or about Oct 31, 2024.
- Delisting effective 10 days after Form 25 filing; trading to continue on OTC Markets Group.
- Form 15 to be filed on or about Nov 11, 2024 to deregister under Exchange Act; reporting obligations suspended immediately.
- Board cites cost savings from SEC reporting, Sarbanes-Oxley compliance, and prior non-compliance (public shell, market value deficiency).
- Common stock suspended from Nasdaq since May 28, 2024 due to Nasdaq's public shell determination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000119312524240034/0001193125-24-240034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000119312524240034/d881100d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-240034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer